eFFECTOR Therapeutics, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$13.7M

249 transactions

Summary

eFFECTOR Therapeutics, Inc. is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $199KSales: $5.9M31 insiders

Date	Insider	Type	Value
2023-11-27	Joint reporting: George Simeon; SR One Capital Fund I Aggregator LP; SR ONE CAPITAL MANAGEMENT, LLC; SR ONE CAPITAL PARTNERS I, LP; SR One Co-Invest I, LLC; SR One Co-Invest I Manager, LLC	Sell	$263K
2023-11-27	Joint reporting: George Simeon; SR One Capital Fund I Aggregator LP; SR ONE CAPITAL MANAGEMENT, LLC; SR ONE CAPITAL PARTNERS I, LP; SR One Co-Invest I, LLC; SR One Co-Invest I Manager, LLC	Sell	$109K
2024-05-15	WORLAND STEPHEN T(Chief Executive Officer)	A	$3K
2024-05-15	Byrnes Michael(Chief Financial Officer)	A	$2K
2023-11-15	Byrnes Michael(Chief Financial Officer)	A	$2K
2024-06-13	Bhatt Elizabeth	A	$0
2024-06-13	Gallagher Brian M. Jr.	A	$0
2024-06-13	Harrington-Smith Kristen	A	$0
2024-06-13	Ehrlich Christopher B	A	$0
2024-06-13	Klencke Barbara	A	$0
2024-06-13	Loewy Caroline M	A	$0
2024-02-19	WORLAND STEPHEN T(Chief Executive Officer)	A	$0
2024-02-19	Warner Douglas J(Chief Medical Officer)	A	$0
2024-02-19	Byrnes Michael(Chief Financial Officer)	A	$0
2024-02-19	Gallagher Brian M. Jr.	A	$0
2024-02-19	Harrington-Smith Kristen	A	$0
2024-02-19	Klencke Barbara	A	$0
2024-02-19	Ehrlich Christopher B	A	$0
2024-02-19	Bhatt Elizabeth	A	$0
2024-02-19	Loewy Caroline M	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

eFFECTOR Therapeutics, Inc. — Contributions, Lobbying & Contracts | Poliscope